Clincosm LogoSign in Get a demo

Hodgkin Disease

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Phoenix, Arizona
  • +53 more
Aug 17, 2022

Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)

Active, not recruiting
Has Results
  • Hodgkin Disease
  • Los Angeles, California
  • +37 more
Oct 25, 2021

Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)

Terminated
Has Results
  • Hodgkin Disease
  • Lymphoma, Non-hodgkin
  • New York, New York
    Columbia University Irving Medical Center - Center for Lymphoid
Jun 28, 2021

Hodgkin Disease Trial in United States (brentuximab vedotin, bendamustine)

Completed
Has Results
  • Hodgkin Disease
  • Birmingham, Alabama
  • +12 more
Jan 24, 2019

Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi Trial in United States (SGN-30 (mAb))

Completed
  • Hodgkin Disease
  • +4 more
  • SGN-30 (monoclonal antibody)
  • Birmingham, Alabama
  • +9 more
Oct 7, 2011

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (Leuprolide acetate depot (LAD) 11.25 mg 3

Terminated
Has Results
  • Hodgkin Disease
  • +3 more
  • Leuprolide acetate depot (LAD) 11.25 mg 3 Month
  • Matched placebo
  • Saint Louis, Missouri
  • +3 more
Apr 9, 2010